2026 · 2nd Quarter (Apr 1 - June 30)

NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH

Filed by NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 20, 2026
Income: Not reported
Expenses: $30,000.00
Registrant: NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH
Client: NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH
Filing UUID: 75c6338a-347e-4f45-ad2c-89c311ec060a
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

TRA · Transportation

Transportation of research animals

BUD · Budget/Appropriations

FY26/27 appropriations, support biomedical research language, NIH funding

MED · Medical/Disease Research/Clinical Labs

Need for continued biomedical research with animal models

HCR · Health Issues

Animal research advancing treatments and cures for humans and animals

ANI · Animals

FY26/27 Approps, Permitting, Support for biomedical research, U.S. competitiveness, The Farm, Food, and National Security Act of 2026 H.R.7567, AFTER Act S.4172, FDA Modernization Act 3.0 H.R.2821, FY26 National Defense Authorization Act H.R.8800

Literal federal measure citations: H.R.7567, S.4172, H.R.2821, H.R.8800

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.